Aberrant activation of NRF2 due to mutations in NRF2 or Keap1, or alterations in upstream signaling pathways, can lead to constitutive expression of antioxidant genes and enhanced resistance to oxidative stress within cancer cells. Here, NFE2L2 is linked to cancer.